Olympus America

Press Center

Olympus Previews PK®7300 Automated Microplate System

Anaheim, CA October 20, 2007- Olympus is previewing its next-generation PK®7300 Automated Microplate System at the AABB Annual Meeting & TXPO 2007 this week. Designed for blood donor centers, the PK7300 system offers the performance that has made Olympus the leader in the Blood Bank market. Olympus systems test more than 90 percent of the North American blood supply1.

The system utilizes the same proven technology, agglutination in the Olympus microtiter plates, as its predecessors – the Olympus PK ® 7100 and PK ® 7200 systems. The PK7300 offers users enhanced process control features, increased throughput, upgraded computer hardware and software, and reduced maintenance.

Additional features include clot detection, reagent monitoring and quality control monitoring, and a flexible, user-friendly Windows®-based computer system. To streamline use and help ensure accurate recordkeeping, it also features extensive online support, with the user manual, troubleshooting guide, training and maintenance videos and information, and maintenance and part usage records all available online. Market launch is anticipated during the fourth quarter of 2007.

For more information on the Olympus PK7300 Automated Microplate System, contact Amy Spizzirri, Olympus America Inc., Phone: 484-896-5244; email amy.spizzirri@olympus.com .

About Olympus Diagnostic Systems Group

Olympus Diagnostic Systems provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physician offices and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, maximize productivity, and deliver fast, reliable results.

About Olympus


Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

· Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;

· Advanced clinical and research microscopes;

· Lab automation systems, chemistry-immuno and blood bank analyzers and reagents;

· Digital cameras and voice recorders.

Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit www.olympusamerica.com .

1According to the 2007 Blood Bank Market Report by the Venture Planning Group there are 18.8 million donors tested for ABO/Rh in the US. An estimate of the number of donors tested on the PK7200 based on our current US customers is approximately 17 million.